Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
News
|
Comment
|
Features
|
Analysis
|
Supplements & Reports
|
People
|
Events
|
Multimedia
|
Science Abstracts
|
Pfizer faces disappointment with anticancers after more Phase III failures
12 March 2010
Pfizer is facing more disappointment with the development of some of its most advanced anticancers after Sutent (sunitinib) failed two more Phase III trials in ...
NICE and drug budgets under the microscope as UK election looms
12 March 2010
In the run up to the general election the UK's three main political parties say they will support the life sciences industry. But victory for any party could ...
Avastin fails only Phase III trial in advanced prostate cancer
12 March 2010
Roche 's Avastin (bevacizumab), the world's best-selling cancer drug, has failed to prolong overall survival in its only Phase III trial in advanced prostate ...
Europe to give €12 million for influenza antiviral projects
12 March 2010
The European Commission will provide €12 million in funding for two new research projects which will develop novel influenza treatments, including against both ...
 
BioInvent signs antibody discovery deal with HGS
12 March 2010
BioInvent and Human Genome Sciences (HGS) have signed a deal to discover, develop and commercialise therapeutic monolconal antibodies that target antigens discovered by HGS. The deal will initially ...
BT Pharma becomes Genticel after fundraising
12 March 2010
BT Pharma has raised €13.1 million in a private financing round and has changed its name to Genticel. Genticel will use the funding to focus its operations on the prevention of cervical cancer in ...
AVEO prices IPO; misses target range
12 March 2010
AVEO Pharmaceuticals has finally launched its IPO, after delaying the pricing by a day. The cancer-focused biopharmaceutical company priced 9 million shares of its common stock at $9 per share after ...
India's Bilcare to open second unit in Wales
12 March 2010
Bilcare Global Clinical Supplies, a provider of clinical trial supplies and services from India, plans to open a second unit in Crickhowell, Wales, in the UK. The new 30,000ft 2 unit is expected to ...
 
US FDA advisory committees back randomised trials for LABA safety
12 March 2010
The US FDA was established in 1931, but only three years ago did it get the power to order drug makers to conduct safety studies of products that have already been approved and put into general use. ...
Actelion needs to provide more info to FDA for Zavesca in Niemann-Pick disease
12 March 2010
The US FDA has issued Actelion with a complete response letter for its drug Zavesca (miglustat), for the treatment of progressive neurological manifestations in adults and children with Niemann-Pick ...
Takara Bio allies with US university for novel HIV gene therapy
12 March 2010
Takara Bio has signed a collaborative research agreement with the University of Pennsylvania in the US for the co-development of an innovative gene-based therapy for HIV. The Japanese firm will work ...
PTC Therapeutics/Genzyme's ataluren fails in Phase IIb muscular dystrophy trial
11 March 2010
PTC Therapeutics and Genzyme 's ataluren, an experimental nonsense mutation suppressor, has failed in nonsense mutation Duchenne/Becker Muscular Dystrophy (nmDBMD), show top-line Phase IIb results. ...
 
Germany to end free pricing for patented medicines
12 March 2010
Germany's health ministry is planning to introduce compulsory price negotiations for patented drugs between the pharmaceutical industry and health insurers, it confirmed to Scrip. The measure could ...
GSK asks US court to block Teva's launch of generic AIDS drug
12 March 2010
GlaxoSmithkline has filed a motion in a US federal court for a preliminary injunction to bar Teva Pharmaceutical Industries from an apparent planned May launch of a generic version of GSK's HIV/AIDS ...
Lithuania's new health minister to tackle corruption and make reforms
12 March 2010
Raimondas Sukys has become Lithuania's new health minister taking over the post from the acting health minister Ingrida Simonyte . Lithuania's president Dalia Grybauskaite has asked him to go ahead ...
Access to medicines concerns in EU-India trade agreement
12 March 2010
The international humanitarian body Médecins Sans Frontières (MSF) has written to the Indian prime minister, Dr Manmohan Singh , expressing concern that the EU-India free trade agreement, which will ...
 
PEOPLE
Clinton-Bush Haiti fund appoints board The Clinton Bush Haiti Fund (CBHF), set up by former US presidents Bill Clinton and George W ...
Iain McGill joins EUSA Pharma EUSA Pharma (UK/US), a speciality pharmaceutical company focused on oncology, pain control and ...
New appointment at Affimed Therapeutics Affimed Therapeutics (Germany) has appointed Dr Christian Hucke to take over responsibility for ...
>> More People News...

EXPERT VIEW
Keeping the faith with anticancers
12 March 2010
Peter Charlish
It has been a bad week for anticancer drug development, with two late-stage projects coming to ...

Market Insight: Big pharma hit by Greece's fiscal crisis
09 March 2010

Hospitals' failure to pay pharmaceutical companies and newly announced price cuts are just some of ...

 Market Insight - Fear gives way to prudence a...

How to run clinical trials in the Middle East - why the GCC?
04 March 2010

A grouping of Middle Eastern countries came together under the auspices of the Gulf Co-operation ...

How to run clinical trials in the Middle East - Jordan
04 March 2010

Jordan has a population of 6.35 million and its GDP per capita is $5,000, while its healthcare ...

MULTIMEDIA
Scrip in a minute - week ending March 12th 12 March 2010

Get the Flash Player to see this player.

Genzyme's gambit: A hedge against Carl Icahn
18 February 2010
Christopher Spillane
The fall in Genzyme 's share price made it an obvious target. The Massachusetts based biotech ...

European Medicines Agency and logos: snakes, DNA and the pestle and mortar
22 December 2009
Elizabeth Sukkar
Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Face to Face with Sandoz's "growth guy" Jeff George
04 March 2010
Eleanor Malone
Jeff George took over as head of Sandoz, Novartis's generics business, in late 2008. With a big ...

CPhI Worldwide 2009
13 October 2009
Scrip's official preview of CPhI Worldwide, ICSE, P-MEC and BioPh 2009

Scrip's Stock Tracker February 2010
12 March 2010
Ashley Yeo
Talk of dividends being under threat at companies such as Bristol-Myers Squibb , Pfizer and Lilly , ...

EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm